Literature DB >> 16639519

Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors.

Ali Gur1, Aysegul Jale Sarac, Yahya Kemal Burkan, Kemal Nas, Remzi Cevik.   

Abstract

We aimed to determine arthritis frequency, quality of life (QoL), anxiety, and depression levels in Behcet's disease (BD) and thereby the effect of joint involvement on QoL, anxiety, and depression. Sixty-three patients diagnosed with BD according to the International Study Group Diagnostic Criteria and 45 healthy subjects as control were included in the study. All patients were evaluated in terms of clinical findings, the number and site of the joints involved, sacroiliac joint involvement, pain intensity, QoL, anxiety, and depression scale. The instruments used were Beck Depression Inventory (BDI) for depression, State-Trait Anxiety Inventory (STAI-T) for anxiety, and Health Assessment Questionnaire (HAQ) and Nottingham Health Profile (NHP) for health status and QoL. Joint involvement was seen in 41.3% of the patients. The most characteristic form was asymmetric oligoarthritis, which was seen in 65.3% of the patients. The joints most commonly involved were found to be in the wrist (53.8%) and knee (50%). Sacroiliitis was found at a rate of 38.1%. In BD patients without arthritis, rates of men (p=0.004) and genital ulcer (p=0.001) were higher, and rates of erythema nodosum (p=0.001) and human leukocyte antigen B5 positivity (p=0.023) were less than those of BD patients with arthritis. Pain intensity (p=0.000), NHP (p=0.004), and HAQ (p=0.003) scores were significantly higher in BD patients with arthritis than those without arthritis. Pain intensity, NHP, BDI, and STAI-T scores were significantly higher in BD patients without arthritis than in healthy controls, while pain intensity, NHP, HAQ, BDI, and STAI-T scores were significantly higher in BD patients with arthritis than in healthy controls (p=0.000). In conclusion, our study establishes that arthropathy is one of the common manifestations of BD. Arthritis in BD affects considerably patients' pain levels and QoL. A multistep approach is required for these patients. We are of the opinion that this approach may also improve the QoL of these patients and prevent the activation of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16639519     DOI: 10.1007/s10067-005-0100-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Audio-vestibular evaluation in patients with Behçet's syndrome.

Authors:  C Evereklioglu; Y Cokkeser; S Doganay; H Er; A Kizilay
Journal:  J Laryngol Otol       Date:  2001-09       Impact factor: 1.469

2.  Recent epidemiological data on Behçet's disease in Iran. The 2001 survey.

Authors:  F Shahram; F Davatchi; A Nadji; A Jamshidi; H Chams; C Chams; N Shafaie; M Akbarian; F Gharibdoost
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

3.  Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire.

Authors:  Ayse A Küçükdeveci; Hülya Sahin; Sebnem Ataman; Bridget Griffiths; Alan Tennant
Journal:  Arthritis Rheum       Date:  2004-02-15

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Characteristics of peripheral arthritis in Behçet's disease.

Authors:  M Calgüneri; S Kíraz; I Ertenli; M Erman; Y Karaarslan; I Celik
Journal:  N Z Med J       Date:  1997-03-14

6.  The prevalence of Behçet's syndrome in a rural area in northern Turkey.

Authors:  S Yurdakul; I Günaydin; Y Tüzün; N Tankurt; H Pazarli; Y Ozyazgan; H Yazici
Journal:  J Rheumatol       Date:  1988       Impact factor: 4.666

Review 7.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

8.  The arthritis of Behçet's disease: a prospective study.

Authors:  S Yurdakul; H Yazici; Y Tüzün; H Pazarli; B Yalçin; M Altaç; Y Ozyazgan; N Tüzüner; A Müftüoğlu
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

9.  Clinical features of Behçet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies?

Authors:  E M El-Ageb; M H Al-Maini; A K Al-Shukaily; Y Al-Farsi; E R Richens
Journal:  Rheumatol Int       Date:  2002-03       Impact factor: 2.631

10.  Arthritis in Behcet's syndrome.

Authors:  N Caporn; E R Higgs; P A Dieppe; I Watt
Journal:  Br J Radiol       Date:  1983-02       Impact factor: 3.039

View more
  18 in total

1.  Cigarette smoking and risk of primary systemic vasculitis: a propensity score matching analysis.

Authors:  Alireza Khabbazi; Babak Alinejati; Mehrzad Hajialilo; Morteza Ghojazadeh; Aida Malek Mahdavi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 2.  Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Authors:  Rosaria Talarico; Laura Palagini; Anna d'Ascanio; Elena Elefante; Claudia Ferrari; Chiara Stagnaro; Chiara Tani; Angelo Gemignani; Mauro Mauri; Stefano Bombardieri; Marta Mosca
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

3.  Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Authors:  Claudia Fabiani; Antonio Vitale; Ida Orlando; Jurgen Sota; Marco Capozzoli; Rossella Franceschini; Mauro Galeazzi; Gian Marco Tosi; Bruno Frediani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2017-06-15       Impact factor: 3.397

4.  Ultrasonographic Measurement of the Femoral Cartilage Thickness in Patients with Behçet's Disease.

Authors:  I Batmaz; M Kara; T Tiftik; M Yildiz; R Çevik; L Özçakar
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

Review 5.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

6.  Does Behcet's disease associate with neuropathic pain syndrome and impaired well-being?

Authors:  Deniz Evcik; Sebnem Koldas Dogan; Saime Ay; Nihan Cuzdan; Munevver Guven; Aysel Gurler; Ayse Boyvat
Journal:  Clin Rheumatol       Date:  2012-09-22       Impact factor: 2.980

7.  The relationship between disease activity and depression in patients with Behcet disease and rheumatoid arthritis.

Authors:  Meltem Alkan Melikoglu; Mehmet Melikoglu
Journal:  Rheumatol Int       Date:  2009-08-06       Impact factor: 2.631

8.  Serum prolidase enzyme activity and oxidative status in patients with Behçet's disease.

Authors:  Mehtap Bozkurt; Hatice Yüksel; Serda Em; Pelin Oktayoglu; Mehmet Yildiz; Dicle Akdeniz; Kemal Nas
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

9.  Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers.

Authors:  Laura B Dunn; Bradley E Aouizerat; Dale J Langford; Bruce A Cooper; Anand Dhruva; Janine K Cataldo; Christina R Baggott; John D Merriman; Marylin Dodd; Claudia West; Steven M Paul; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2012-11-24       Impact factor: 2.398

10.  The Behcet's Disease Quality of Life: reliability and validity of the Korean version.

Authors:  Sang Won Yi; Ji-Hae Kim; Ki-Young Lim; Dongsik Bang; Sungnack Lee; Eun-So Lee
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.